PHASE I/II CLINICAL TRIAL OF AN ACTIVATED WHOLE TUMOR CELL VACCINE FOLLOWED BY TRANSFER OF IMMUNE T CELLS IN PATIENTS WITH MANTLE CELL LYMPHOMA. (June 2017)

• Record Type: Journal Article
• Authors: Frank, M.; Khodadoust, M.; Chu, M.; Kohrt, H.; Advani, R.; Alizadeh, A.; Reddy, S.; Maeda, L.; Gupta, N.; Laport, G.; Meyer, E.; Miklos, D.; Negrin, R.; Rezvani, A.; Weng, W.; Sheehan, K.; Czerwinski, D.; Faham, M.; Okada, A.; Moore, H.; Phillips, D.; Wapnir, I.; Brody, J.; Levy, R.
• Is Part Of: Hematological oncology. Volume 35(2017)Supplement 2
• Page Start: 207
• Page End: 208
• Publication Date: 2017-06
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.2438_72
• Languages: English
• ISSNs: 0278-0232